Anúncio
Anúncio
SLXN
Silexion Therapeutics Corp Ordinary Shares
2.13
USDPatrocinado
+0.02
+1.19%
08 de jan., 15:52 UTC -5
Encerrado
Pós-Mercado
2.11
-0.01
-0.66%
Relatórios de Lucros SLXN
Rácio de surpresa positiva
SLXN separação 2 de 5 últimas estimativas.
40%
Próximo Relatório
Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/--
Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue
On 12 de nov. de 2025, SLXN reported earnings of -2.88 USD per share (EPS) for Q3 25, beating the estimate of -3.46 USD, resulting in a 16.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.56% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Silexion Therapeutics Corp Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$2.88, beating estimates by 16.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Silexion Therapeutics Corp Ordinary Shares's Q3 2025 earnings?
The stock price moved up 3.56%, changed from $2.81 before the earnings release to $2.91 the day after.
When is Silexion Therapeutics Corp Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Silexion Therapeutics Corp Ordinary Shares's next earnings report?
Based on --
analistas, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio